Showing 661-670 of 822 results for "".
Chronic Facial Weakness and Deafness
https://practicalneurology.com/diseases-diagnoses/stroke/chronic-facial-weakness-and-deafness/31104/A 66-year-old Indian man reported bilateral facial weakness that started when he was 15 to 20 years old and affected both upper and lower parts of the face. Two to three years later, he developed hoarseness and was found to have bilateral vocal cord paralysis, which required a tracheostomy several y- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31204/Summary of Recent Advances and Findings in NeurologyThe 2007 American Stroke Association’s International Stroke Conference in San Francisco highlighted critical barriers in stroke management and innovative therapeutic advancements. A significant finding revealed that approximately 50% of individuals
- Editorial Board & Contributorshttps://practicalneurology.com/columns/practice-management/editorial-board-contributors/31058/The January 2008 issue of *Practical Neurology* features a distinguished editorial board and contributor lineup, underscoring the journal’s commitment to advancing neurological medicine. Led by Dr. Stephen Gollomp, Chief of Neurology at Lankenau Hospital and Clinical Professor at Thomas Jefferson Un
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31430/July 2005 Highlights from Practical NeurologyHeadaches remain a prevalent yet often misunderstood neurological condition. At the American Headache Society's 47th Annual Scientific Meeting in Philadelphia, advancements in diagnosis and treatment garnered significant attention. Dr. David W. Dodick fro
Beyond the Symptoms: The True Impact of gMG on Patients' Lives
https://practicalneurology.com/programs/cme/beyond-the-symptoms-the-true-impact-of-gmg-on-patients-lives/32235/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.FcRn Antagonists in Myasthenia Gravis: A New Era in Targeted Therapy
https://practicalneurology.com/programs/cme/fcrn-antagonists-in-myasthenia-gravis-a-new-era-in-targeted-therapy/32242/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Precision Medicine in Myasthenia Gravis: Crafting Personalized Treatment Strategies
https://practicalneurology.com/programs/cme/precision-medicine-in-myasthenia-gravis-crafting-personalized-treatment-strategies/32244/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Diagnosing gMG: Navigating Current Tools and Approaches
https://practicalneurology.com/programs/cme/diagnosing-gmg-navigating-current-tools-and-approaches/32238/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Life-Threatening Events: Understanding and Preventing Myasthenic Crisis
https://practicalneurology.com/programs/cme/life-threatening-events-understanding-and-preventing-myasthenic-crisis/32237/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Autoantibodies in MG: Their Role in Diagnosis and Treatment
https://practicalneurology.com/programs/cme/autoantibodies-in-mg-their-role-in-diagnosis-and-treatment/32239/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.